Unichem Pharmaceuticals Recalls Cyclobenzaprine Tablets Due to Labeling Error
Unichem Pharmaceuticals recalled 230 bottles of Cyclobenzaprine Hydrochloride Tablets on August 27, 2025. The recall stems from a labeling mix-up with Meloxicam tablets, which could lead to serious health risks. Consumers should stop using the product immediately and contact their healthcare provider.
Hazard Information
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Unichem Pharmaceuticals USA Inc. or your healthcare provider for guidance. Notification method: Press Release
Product Details
The recalled product is Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, in 90-count bottles. It was manufactured by Unichem Laboratories, Ltd. and distributed nationwide in the USA.
The Hazard
The recall was initiated due to a labeling error that mixed up Cyclobenzaprine Hydrochloride Tablets with Meloxicam USP, 7.5 mg tablets. This mix-up poses a risk of patients receiving the wrong medication, which could lead to adverse health effects.
Reported Incidents
As of the recall date, no injuries have been reported. However, the potential for misuse of the medication due to labeling confusion remains a serious concern.
What to Do
Consumers should stop using the recalled tablets immediately. Contact Unichem Pharmaceuticals USA Inc. or your healthcare provider for further guidance and information on returning the product.
Contact Information
For further assistance, consumers can reach Unichem Pharmaceuticals at their official website or by calling customer service.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.